Technology In Cancer Research & Treatment

Technology In Cancer Research & Treatment

癌症研究与治疗技术

  • 3区 中科院分区
  • Q3 JCR分区

期刊简介

《Technology In Cancer Research & Treatment》是由SAGE Publications Inc.出版社于2002年创办的英文国际期刊(ISSN: 1533-0346,E-ISSN: 1533-0338),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCI、SCIE收录期刊(JCR分区 Q3,中科院 3区),本刊采用OA开放获取模式(OA占比1%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比77.08%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在144篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Technology In Cancer Research & Treatment审稿周期约为约2月。该刊近年未被列入国际预警名单,年发文量约144篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 144 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
4区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 185 / 333

44.6

学科:ONCOLOGY SCIE Q3 210 / 333

37.09

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 160 / 328

51.4

学科:ONCOLOGY SCIE Q3 198 / 328

39.79

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 163 / 322

49.5

学科:ONCOLOGY SCIE Q3 203 / 322

37.11

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.2 SJR:0.674 SNIP:0.746
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q2 146 / 428

66%

大类:Medicine 小类:Cancer Research Q3 121 / 233

48%

期刊发文

  • IGF2BP3 Promotes Head and Neck Squamous Cell Carcinoma Progression via the M6A-LDHA-Lactate-H4K8la Axis and E2F2 Activatio

    Author: Wu, Fan; Zeng, Yulu; Hu, Yunlong; Xie, Zihui; Shen, Rong; Zhou, Jiaxin; Zhou, Pingting; Tong, Shanshan; Liu, Yehai

    Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2026; Vol. 25, Issue , pp. -. DOI: 10.1177/15330338261447338

  • Effect of Perioperative Glutamine-Enhanced Parenteral Nutrition on Short-Term Outcomes in Colorectal Cancer Patients Undergoing Radical Resection: A Systematic Review and Meta-Analysis of Randomized Controlled Trial

    Author: Huang, Yong; Yang, Xiuzhi; Qin, Songhan; Zhang, Tao; Xie, Ming; Wang, Jiwei

    Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2026; Vol. 25, Issue , pp. -. DOI: 10.1177/15330338261438204

  • Role of Bioinformatics in Identifying Novel Biomarkers for Immune Cell Exhaustion and Tumor Microenvironmen

    Author: Huang, Yanxia; Ding, Huizhe; Chai, Yinying; Ding, Yun; Chi, Jiajia; Ying, Jiajia; Bian, Xuemei; He, Yibo; Cai, Wenyu

    Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2026; Vol. 25, Issue , pp. -. DOI: 10.1177/15330338261441019

  • Innovative Value of Amide Proton Transfer Imaging in the Diagnosis and Treatment of Brain Gliomas: From Basic Principles to Clinical Application

    Author: Yao, Changyue; Hu, Weiguo; Liu, Huali; Ran, Zhihong; Hou, Jingrui; Song, Qibin

    Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2026; Vol. 25, Issue , pp. -. DOI: 10.1177/15330338261441683

  • The Prognostic Value of SERPINE1 in Clinical Outcomes in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysi

    Author: Yan, Shifeng; Li, Xinyu; Zhu, Changyu; Li, Wei

    Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2026; Vol. 25, Issue , pp. -. DOI: 10.1177/15330338261435460

  • Value Analysis of MRI Habitat Analysis Combined Model in the Diagnosis of Ovarian Tumor

    Author: Wang, Junying; Liu, Kang; Sui, Yan; Ma, Siyu; Yang, Dewu

    Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2026; Vol. 25, Issue , pp. -. DOI: 10.1177/15330338261439633

  • Outsmarting Metastatic Prostate Cancer: Integration of Imaging, Liquid Biopsies and Biomarkers With Artificial Intelligenc

    Author: He, Jun-Xian; Li, Luyuan; Chen, Shuhong; Chen, Rong-Jun; Zhuang, Jia-Le; Liu, Chang; Burrow, Wesley; Chang, Jonghoon; Tanziela, Tanziela; Bonfil, R. Daniel; Wong, Nai-Kei; Tao, Wensi

    Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2026; Vol. 25, Issue , pp. -. DOI: 10.1177/15330338261440434

  • Economic Evaluation of Inavolisib Combined With Palbociclib-Fulvestrant for PIK3CA-Mutated, HR+/HER2-Advanced Breast Cancer in US

    Author: Zeng, Hanqing; Song, Li-Ying; Guo, Ren; Ding, Dan; Zeng, Xiaohui; Liu, Qiao

    Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2026; Vol. 25, Issue , pp. -. DOI: 10.1177/15330338261444965